Phase 2 RCT in 241 adults with frequent symptomatic premature atrial contractions: 6 weeks of memantine reduced PAC count more than placebo (difference 47.1 percentage points; P=0.0045). Secondary: new-onset AF 4.8% vs 23.9%. No drug-related serious adverse events.
RCTn = 241
Shen et al. Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial